China Medical System Holdings Ltd Financials

Market Capitalization HK$17.35 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	11.97
Forward PE	7.89
Price to Sales TTM	HK$2.47
Price to Book MRQ	HK$1.09
Enterprise to Revenue	1.80
Enterprise to EBITDA	6.70

Financial Reports as of Jun. 30, 2018

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2018-06-30
Profit Margin	19.82%
Operating Margin	22.96%
Return on Assets TTM	5.71%
Return on Equity TTM	8.57%

Income Statement

Revenue TTM	HK$7,527,962,953
Revenue per Share TTM	HK$2.87
Quarterly Revenue Growth	-21.70%
Gross Profit TTM	HK$5,544,970,011
EBITDA	HK$3,541,262,000
Net Income to Common TTM	HK$1,492,139,102
Diluted EPS TTM	HK$0.60
Quarterly Earnings Growth YoY	-52.60%

Balance Sheet

Total Cash MRQ	HK$6,486,199,055
Total Cash per Share MRQ	HK$2.50
Total Debt MRQ	HK$
Total Debt to Equity MRQ	7.15
Current Ratio MRQ	4.28
Book Value per Share MRQ	HK$6.59

Cash Flow

Operating Cash Flow TTM	HK$2,023,010,684
Levered Free Cash Flow TTM	HK$1,100,725,443

0867 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	2,416,529,920
Float Shares	1,171,460,763
Avg 10 Volume	4,268,040
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	51.04%
% Held by Institutions	18.15%

Stock Price Summary

Beta	0.93
Fifty Two Week Low	HK$6.23
Fifty Two Week High	HK$13.16
Fifty Two Week Change	-66.90%
Day 50 MA	HK$7.49
Day 200 MA	HK$7.36

Dividends and Splits

Forward Annual Dividend Rate	HK$0.33
Forward Annual Dividend Yield	4.64%
Trailing Annual Dividend Rate	HK$0.25
Trailing Annual Dividend Yield	3.54%
Payout Ratio	69.72%
Dividend Date
Ex Dividend Date	2024-08-29
Last Split Factor
Last Split Date	2012-04-27